Effectiveness of a Multidisciplinary Treatment Program for Severe Obesity in Adults Based on the Clinically Significant Weight Loss
- PMID: 40566475
- PMCID: PMC12194354
- DOI: 10.3390/jfmk10020225
Effectiveness of a Multidisciplinary Treatment Program for Severe Obesity in Adults Based on the Clinically Significant Weight Loss
Abstract
Background: Obesity is a chronic and complex disease; by its nature, it represents an enormous challenge to be solved and managed. For that matter, several guidelines have been published, but there is still a long way to go until concrete scaled results can be presented. Adults with obesity, and especially severe obesity, need to have access to treatment programs, but they are not available for the vast majority of the population. Objective: The aim of this study is to evaluate the effectiveness of a multidisciplinary treatment program for obesity (MTPO) offered to adults (ages 18 to 50 years old) with a BMI over 30 kg/m2. Methods: Participants were invited through media ads, resulting in 404 participants for the first phase of that study, from whom the risk profile was assessed. After that, 180 participants (82.8% with severe obesity) concluded the MTPO, which consisted of 48 sessions of exercises and the same number of professional orientations about a healthy lifestyle, including the importance of being physically active, how to improve their eating habits, and how to control their emotions. Results: For the analysis of results, participants were grouped according to their weight loss in terciles, with the first, tercile presenting an average weight loss of 7.6%, which is considered clinically significant. In the same way, the average percental variations were even higher in this group for body fat (12.7%) and the lean mass to fat mass ratio (LM/FM), which increased by 14.3%. The homeostatic model assessment for insulin resistance, HOMA-IR, was around 3 times the variation of body mass, whereas the triglycerides (TG) and the hemoglobin A1C (H1Ac) were around twice that rate. Conclusions: These results made clear the effectiveness of the MTPO, which needs to be tested in public health services.
Keywords: Brazil; effectiveness; multidisciplinary treatment; obesity; severe obesity; weight loss.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843. JBI Database System Rev Implement Rep. 2016. PMID: 27532314
References
-
- World Obesity Federation . Obesity: Missing the 2025 Global Targets. World Obesity Federation; London, UK: 2020. pp. 1–242.
-
- Brasil . Vigitel Barsil 2023. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente; Departamento de Análise Epidemiológica e Vigilância de Doenças Não Transmissíveis; Vigitel Brazil 2023; Ministério da Saúde; Brasilia, Brasil: 2023.
-
- Brasil . Vigitel Brasil 2018: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquerito Telefônico. G. Estatística e Informação em Saúde; Ministério da Saúde; Brasilia, Brasil: 2019. 131p
-
- Brasil . Ministério da Saúde. Plano de Ações Estratégicas para o Enfrentamento Das Doenças Crônicas E Agravos. Volume 1. Ministério da Saúde; Brasília, Brasil: 2021. 121p
LinkOut - more resources
Full Text Sources
Miscellaneous